MSLP

Muscle Pharm (CE) (MSLP)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:MSLP
DataOraFonteTitoloSimboloCompagnia
10/03/202322:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
21/12/202223:22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:MSLPMuscle Pharm Corporation (CE)
17/08/202212:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:MSLPMuscle Pharm Corporation (CE)
28/07/202222:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:MSLPMuscle Pharm Corporation (CE)
17/06/202212:04Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:MSLPMuscle Pharm Corporation (CE)
16/05/202223:08Edgar (US Regulatory)Quarterly Report (10-q)USOTC:MSLPMuscle Pharm Corporation (CE)
31/03/202222:01Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:MSLPMuscle Pharm Corporation (CE)
27/07/202101:16GlobeNewswire Inc.MusclePharm Closes Potential $7.3 Million Liability with IRSUSOTC:MSLPMuscle Pharm Corporation (CE)
20/07/202123:13Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:MSLPMuscle Pharm Corporation (CE)
11/06/202123:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:MSLPMuscle Pharm Corporation (CE)
29/03/202123:19Edgar (US Regulatory)Annual Report (10-k)USOTC:MSLPMuscle Pharm Corporation (CE)
26/03/202122:17Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)USOTC:MSLPMuscle Pharm Corporation (CE)
08/11/201918:27Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:MSLPMuscle Pharm Corporation (CE)
26/10/201823:15Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:MSLPMuscle Pharm Corporation (CE)
10/09/201823:04Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:MSLPMuscle Pharm Corporation (CE)
29/06/201823:35Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:MSLPMuscle Pharm Corporation (CE)
04/12/201720:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:MSLPMuscle Pharm Corporation (CE)
20/10/201722:16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:MSLPMuscle Pharm Corporation (CE)
01/05/201720:07Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:MSLPMuscle Pharm Corporation (CE)
19/04/201712:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:MSLPMuscle Pharm Corporation (CE)
19/01/201718:58Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:MSLPMuscle Pharm Corporation (CE)
03/11/201614:15InvestorsHub NewsWireGlobal Sports Nutrition & Energy Drink Markets Push Billion Dollar Revenues HigherUSOTC:MSLPMuscle Pharm Corporation (CE)
18/07/201622:50Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:MSLPMuscle Pharm Corporation (CE)
11/02/201619:16Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:MSLPMuscle Pharm Corporation (CE)
16/12/201522:03Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:MSLPMuscle Pharm Corporation (CE)
04/12/201522:31Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:MSLPMuscle Pharm Corporation (CE)
07/04/201514:00InvestorsHub NewsWireCapRock Research Issues Analyst Report on Avra, Inc. (OTCQB: AVRN): Pioneering Product Innovation in Growing Bitcoin MarketUSOTC:MSLPMuscle Pharm Corporation (CE)
24/07/201414:15GlobeNewswire Inc.MusclePharm Nominated for 25 Bodybuilding.com AwardsUSOTC:MSLPMuscle Pharm Corporation (CE)
11/07/201422:27Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:MSLPMuscle Pharm Corporation (CE)
24/06/201414:05MarketwiredMusclePharm Strengthens Retail Presence With GNCUSOTC:MSLPMuscle Pharm Corporation (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:MSLP
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network